Marshfield Clinic Health System First to Use CYTALUX Imaging Agent

Monday, July 8th, 2024 -- 11:00 AM

The Marshfield Clinic Health System recently became the first healthcare system in the world to use the novel imaging agent, CYTALUX, in combination with the Stryker 1788 imaging platform for ovarian cancer surgery since CYTALUX received U.S. Food and Drug Administration approval.

The new technology, CYTALUX, aids in ovarian cancer cytoreduction, or surgery to remove the tumor and any nearby tissues the cancer spread to.

Feel free to contact us with questions and/or comments.